Building Community through Activity
MUSCLES FOR MYELOMA - September 24, 2020
We are almost to the goal with our Muscles4Myeloma September Blood Cancer Awareness month. We are excited to announce that with over 485 participants, we ... Read More
Myeloma Coach's Offer Caregiver Support
Myeloma Coach's Offer Caregiver Support
MYELOMA COACH - September 24, 2020
September is Blood Cancer Awareness month. It is a great time to spread awareness about blood cancers including multiple myeloma. Many individuals ha... Read More
HealthTree University: Starting Treatment (Part 3 of 3)
HealthTree University: Starting Treatment (Part 3 of 3)
HEALTHTREE - September 24, 2020
Below are some video excerpts from our HealthTree University curriculum to help you learn more about these important areas of your disease. By creating a Health... Read More
How Pomalidomide Works to Kill Multiple Myeloma
MYELOMA 101 - September 23, 2020
The immunomodulators (thalidomide, lenalidomide and pomalidomide) are a staple class of drugs regularly used in myeloma care. Pomalidomide is often used on... Read More
MCRT Webcast: Myeloma Genetics with Three Experts
MC ROUND TABLES - September 22, 2020
Knowing about genetics is not just for scientists anymore. To be an informed myeloma patient it is essential to know what your specific genetic markers ar... Read More
Exercise and Mental Health
MUSCLES FOR MYELOMA - September 22, 2020
September is Blood Cancer Awareness Month. To celebrate the Month, the Myeloma Crowd is running a 30 day Muscles4Myeloma Fitness Challenge. Get moving... Read More
FDA Grants Orphan Drug Status to New CD38 Antibody Redirecting Molecule (ARM) Myeloma Therapy
MYELOMA NEWS - September 18, 2020
The FDA has granted Orphan Drug designation to a new type of myeloma therapy called an Antibody Redirecting Molecule (ARM) targeting CD38. The orphan drug ... Read More
MRD Negativity is Better than Stringent Complete Response (sCR) to Determine Myeloma Patient Outcomes
MYELOMA NEWS - September 17, 2020
In a head-to-head study comparing minimal residual disease (MRD) testing vs. using the "stringent complete response" measurement, MRD indicated a more... Read More
Finding Balance with New Routines
LIFE WITH MYELOMA - September 17, 2020
September is Blood Cancer Awareness Month. To celebrate the Month, the Myeloma Crowd is running a 30 day Muscles4Myeloma Fitness Challenge. Get moving... Read More
HealthTree University: Starting Treatment (Part 2 of 3)
HEALTHTREE - September 17, 2020
There is so much to learn when you're starting myeloma treatment! How do you choose a transplant, induction therapy, consolidation therapy, maintenance ther... Read More
Financial Coach: Understanding Medicare And When To Shop Around For Best Coverage–Part 1
MYELOMA COACH - September 16, 2020
This is part one in a series of articles to assist you in preparing for Medicare enrollment and health insurance review. This article will be a refres... Read More
MGUS and Smoldering Myeloma: Register Now for the Myeloma Crowd Round Table Interactive Webcast on September 26
UPCOMING MC ROUND TABLES - September 15, 2020
MGUS and Smoldering Myeloma: Understanding Risk, Progression, and Clinical Trials Register Now Precursor conditions of myeloma may or ... Read More
Muscles for Myeloma: Low Intensity, Long Duration Exercise
MUSCLES FOR MYELOMA - September 15, 2020
September is Blood Cancer Awareness Month. To celebrate the Month, the Myeloma Crowd is running a 30 day Muscles4Myeloma Fitness Challenge. Get moving... Read More
